WHO WE ARE
AfroCentric is a black-owned JSE-listed investment holding company providing services and products to the healthcare sector.
The Group was founded in 2008 on the core philosophy of promoting transformation and empowerment.
WHAT WE DO
Our business is focused on making a sustainable impact in the area we know best – healthcare. Through our operating
subsidiaries, we increase access to sustainable, affordable and quality healthcare by providing health administration, healthrisk
management and a range of complementary solutions across the healthcare value chain to our medical scheme clients and
their members. A primary lever in our strategy is to reduce the cost of healthcare.
Why we exist
|
|
Where we are going
|
|
How we will get there
|
|
What it will require of us
|
|
|
|
|
|
|
|
|
|
Our purpose
Enhancing quality of life
|
|
Our vision
Transforming healthcare
|
|
Our mission
To innovate a new
integrated model of
sustainable healthcare
that measurably
improves access to
quality healthcare
|
|
Our values
- Act with integrity and trust
- Go the extra mile
- Cultivate uniqueness
- Thrive together
- Make a positive difference
|
WHERE WE OPERATE
We operate in six Southern African countries through the following companies:
 |
|
1. South Africa
Medscheme South Africa
Aid for AIDS
AfroCentric Health
Solutions
Pharmacy Direct
Curasana
Activo Health
Scriptpharm Risk
Management
MMed Distribution
Allegra
AfroCentric Technologies
EssentialMed
Klinikka
Wellness Odyssey
The Cheese Has Moved
AfroCentric Distribution
Services
Tendahealth
AfroCentric Integrated
Corporate Solutions
PHA
DENIS
|
|
2. Namibia
Medscheme Namibia
3. Botswana
Associated Fund
Administrators
4. Zimbabwe
Medscheme Zimbabwe
5. Eswatini
Medscheme
Administrators Eswatini
Medscheme Health
Insurance Eswatini
6. Mauritius
Medscheme Mauritius
Medscheme International
|
| |
|
|
|
|
INVESTMENT CASE
Our diversified business model and growth strategy enable us to achieve sustainable growth and value creation across the healthcare sector by leveraging our competitive advantages.
Our strong investment case was demonstrated during the year through our agile response and resilience in the face of the coronavirus (COVID-19) pandemic. Despite the challenges faced, we were able to leverage our diversified business units to ensure we met our client service level agreements.
Strong market
positioning
- One of the largest health
administration businesses in the
South African healthcare sector
- An established track record as a
medical scheme administrator –
3.8 million lives under our care
(39.55% of market share)
- An integrated healthcare
business and market leader in
managed care
- The largest distributor of chronic
medicine to public hospitals and
clinics
- Approximately 10 million scripts
dispensed per annum – public
sector makes up 80% of the total
prescriptions dispensed
(For more information, please see our
business model and the Group
CEO's review)
Diversified across
complementary
healthcare services
- A diversified healthcare business
with growing exposure across the
healthcare value chain in South
Africa – pharmaceutical business
generates 49% of revenue
- Increased diversification enables
us to optimise our clients'
healthcare costs
- A presence in other Southern
Africa countries
- Diversification makes us more
sustainable in a changing
healthcare environment
(For more information, please see our
business model)
Multiple
growth drivers
- Maximising value with our new
integrated business model
- Optimising value chain to enhance
efficiencies and reduce healthcare
costs
- Digitising to improve client
experience – one million claims
processed by robotic process
automation (RPA)
- Leveraging healthcare and
financial services opportunities
with Sanlam partnership
- Positioning for success in
National Health Insurance (NHI)
environment
(For more information, please see our
business model and the Group
CEO's review)
View investment case
EMPLOYEES
